219 related articles for article (PubMed ID: 24782263)
1. Hepatic pathology among patients without known liver disease undergoing bariatric surgery: observations and a perspective from the longitudinal assessment of bariatric surgery (LABS) study.
Kleiner DE; Berk PD; Hsu JY; Courcoulas AP; Flum D; Khandelwal S; Pender J; Pomp A; Roerig J; Machado LL; Wolfe BM; Belle SH;
Semin Liver Dis; 2014 Feb; 34(1):98-107. PubMed ID: 24782263
[TBL] [Abstract][Full Text] [Related]
2. High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery.
Xanthakos SA; Jenkins TM; Kleiner DE; Boyce TW; Mourya R; Karns R; Brandt ML; Harmon CM; Helmrath MA; Michalsky MP; Courcoulas AP; Zeller MH; Inge TH;
Gastroenterology; 2015 Sep; 149(3):623-34.e8. PubMed ID: 26026390
[TBL] [Abstract][Full Text] [Related]
3. Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.
Rastogi A; Shasthry SM; Agarwal A; Bihari C; Jain P; Jindal A; Sarin S
APMIS; 2017 Nov; 125(11):962-973. PubMed ID: 29076589
[TBL] [Abstract][Full Text] [Related]
4. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
Verma S; Jensen D; Hart J; Mohanty SR
Liver Int; 2013 Oct; 33(9):1398-405. PubMed ID: 23763360
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic Steatohepatitis Is Associated With Increased Mortality in Obese Patients Undergoing Bariatric Surgery.
Goossens N; Hoshida Y; Song WM; Jung M; Morel P; Nakagawa S; Zhang B; Frossard JL; Spahr L; Friedman SL; Negro F; Rubbia-Brandt L; Giostra E
Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1619-1628. PubMed ID: 26492845
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and prevalence of liver disease in review of 2557 routine liver biopsies performed during bariatric surgery.
Udelsman BV; Corey KE; Lindvall C; Gee DW; Meireles OR; Hutter MM; Chang DC; Witkowski ER
Surg Obes Relat Dis; 2019 Jun; 15(6):843-849. PubMed ID: 31014948
[TBL] [Abstract][Full Text] [Related]
8. Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.
Aminian A; Al-Kurd A; Wilson R; Bena J; Fayazzadeh H; Singh T; Albaugh VL; Shariff FU; Rodriguez NA; Jin J; Brethauer SA; Dasarathy S; Alkhouri N; Schauer PR; McCullough AJ; Nissen SE
JAMA; 2021 Nov; 326(20):2031-2042. PubMed ID: 34762106
[TBL] [Abstract][Full Text] [Related]
9. Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease.
Cherla DV; Rodriguez NA; Vangoitsenhoven R; Singh T; Mehta N; McCullough AJ; Brethauer SA; Schauer PR; Aminian A
Surg Endosc; 2020 May; 34(5):2266-2272. PubMed ID: 31359195
[TBL] [Abstract][Full Text] [Related]
10. Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis.
Lassailly G; Caiazzo R; Ntandja-Wandji LC; Gnemmi V; Baud G; Verkindt H; Ningarhari M; Louvet A; Leteurtre E; Raverdy V; Dharancy S; Pattou F; Mathurin P
Gastroenterology; 2020 Oct; 159(4):1290-1301.e5. PubMed ID: 32553765
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of bariatric surgery in patients with advanced fibrosis.
Singh T; Kochhar GS; Goh GB; Schauer P; Brethauer S; Kroh M; Aminian A; Lopez R; Dasarathy S; McCullough AJ
Int J Obes (Lond); 2017 Mar; 41(3):443-449. PubMed ID: 27881858
[TBL] [Abstract][Full Text] [Related]
12. The HAALT Non-invasive Scoring System for NAFLD in Obesity.
Sheth H; Bagasrawala S; Shah M; Ansari R; Olithselvan A; Lakdawala M
Obes Surg; 2019 Aug; 29(8):2562-2570. PubMed ID: 31016455
[TBL] [Abstract][Full Text] [Related]
13. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
[TBL] [Abstract][Full Text] [Related]
14. Probability-based interpretation of liver stiffness measurement in untreated chronic hepatitis B patients.
Wong VW; Lampertico P; de Lédinghen V; Chang PE; Kim SU; Chen Y; Chan HL; Mangia G; Foucher J; Chow WC; Ahn SH; Hou J
Dig Dis Sci; 2015 May; 60(5):1448-56. PubMed ID: 25563720
[TBL] [Abstract][Full Text] [Related]
15. Histological findings and NAFLD/NASH Status in liver biopsies of patients subjected to bariatric surgery.
Malucelli M; Strobel R; Ivantes C; Sakamoto D; Luís Duarte M; Lucia Alves Pedroso M
Arch Endocrinol Metab; 2023 Nov; 68():e220138. PubMed ID: 37948562
[TBL] [Abstract][Full Text] [Related]
16. Visual Liver Score to Stratify Non-Alcoholic Steatohepatitis Risk and Determine Selective Intraoperative Liver Biopsy in Obesity.
Ooi GJ; Burton PR; Earnest A; Laurie C; Kemp WW; Nottle PD; McLean CA; Roberts SK; Brown WA
Obes Surg; 2018 Feb; 28(2):427-436. PubMed ID: 28776153
[TBL] [Abstract][Full Text] [Related]
17. Significant fibrosis assessed by liver biopsy among Chinese bariatric surgery patients: A prospective cross-sectional study.
Huang Y; Dong S; Wang C; Dong Z; Chen W
Front Endocrinol (Lausanne); 2023; 14():1090598. PubMed ID: 36793287
[TBL] [Abstract][Full Text] [Related]
18. Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease.
Petta S; Wai-Sun Wong V; Bugianesi E; Fracanzani AL; Cammà C; Hiriart JB; Lai-Hung Wong G; Vergniol J; Wing-Hung Chan A; Giannetti A; Merrouche W; Lik-Yuen Chan H; Le-Bail B; Lombardi R; Guastella S; Craxì A; de Ledinghen V
Am J Gastroenterol; 2019 Jun; 114(6):916-928. PubMed ID: 31169533
[TBL] [Abstract][Full Text] [Related]
19. SHOULD ROUTINE LIVER BIOPSY BE CONSIDERED IN BARIATRIC SURGICAL PRACTICE? AN ANALYSIS OF THE LIMITATIONS OF NON-INVASIVE NAFLD MARKERS.
Concon MM; Gestic MA; Utrini MP; Chaim FDM; Chaim EA; Cazzo E
Arq Gastroenterol; 2022; 59(1):110-116. PubMed ID: 35442320
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the nonalcoholic fat liver disease fibrosis score for patients undergoing bariatric surgery.
Pimentel SK; Strobel R; Gonçalves CG; Sakamoto DG; Ivano FH; Coelho JC
Arq Gastroenterol; 2010; 47(2):170-3. PubMed ID: 20721462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]